Penn Capital Management Company, LLC Chimerix Inc Transaction History

Penn Capital Management Company, LLC

  • $957 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 09, 2022
BUY
$1.81 - $2.76 $43,081 - $65,693
23,802 New
23,802 $46,000
Q2 2022

Aug 15, 2022
BUY
$1.34 - $5.34 $1.14 Million - $4.53 Million
847,981 New
847,981 $1.76 Million
Q1 2022

May 17, 2022
SELL
$4.58 - $6.8 $617,242 - $916,429
-134,769 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$5.94 - $8.75 $454,635 - $669,707
76,538 Added 131.44%
134,769 $834,000
Q2 2021

Aug 16, 2021
BUY
$7.54 - $9.79 $439,061 - $570,081
58,231 New
58,231 $466,000

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email